MACI vs GPAT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

MACI

46.9
AI Score
VS
GPAT Wins

GPAT

50.0
AI Score

Investment Advisor Scores

MACI

47score
Recommendation
HOLD

GPAT

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MACI GPAT Winner
Net Income 1.50M 2.44M GPAT
Operating Income -1.37M -2.03M MACI
ROE -43.0% -15.0% GPAT
ROA 3.2% 2.5% MACI
Total Assets 47.02M 98.35M GPAT
Cash 2,068 571,765 GPAT
Current Ratio 0.70 0.05 MACI

Relative Price Performance (Last 90 Days)

MACI 1M: +0.7% · 3M: +1.5% GPAT 1M: +0.3% · 3M: —

Current Technical Phase

MACI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 59.3 · Price: $10.83

GPAT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 51.5 · Price: $10.87

Fundamentals Snapshot

Metric MACI GPAT
Market Cap
Forward P/E 0.0 0.0
Trailing P/E 61.0 44.6
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin
Operating Margin 0.0% 0.0%
EPS 0.18 0.25
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, GPAT is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.